392 related articles for article (PubMed ID: 25445537)
1. The enhancement of gene silencing efficiency with chitosan-coated liposome formulations of siRNAs targeting HIF-1α and VEGF.
Şalva E; Turan SÖ; Eren F; Akbuğa J
Int J Pharm; 2015 Jan; 478(1):147-154. PubMed ID: 25445537
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of optimized liposomes for delivery of small interfering RNA.
Yang T; Bantegui T; Pike K; Bloom R; Phipps R; Bai S
J Liposome Res; 2014 Dec; 24(4):270-9. PubMed ID: 24708056
[TBL] [Abstract][Full Text] [Related]
3. Insights into the therapeutic potential of hypoxia-inducible factor-1α small interfering RNA in malignant melanoma delivered via folate-decorated cationic liposomes.
Chen Z; Zhang T; Wu B; Zhang X
Int J Nanomedicine; 2016; 11():991-1002. PubMed ID: 27042054
[TBL] [Abstract][Full Text] [Related]
4. Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression.
Hajizadeh F; Moghadaszadeh Ardebili S; Baghi Moornani M; Masjedi A; Atyabi F; Kiani M; Namdar A; Karpisheh V; Izadi S; Baradaran B; Azizi G; Ghalamfarsa G; Sabz G; Yousefi M; Jadidi-Niaragh F
Eur J Pharmacol; 2020 Sep; 882():173235. PubMed ID: 32574672
[TBL] [Abstract][Full Text] [Related]
5. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effect of interfering RNA targeting HIF-1alpha and VEGF on retinal neovascularization in the mouse].
Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
Zhonghua Yan Ke Za Zhi; 2008 Oct; 44(10):921-8. PubMed ID: 19176122
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of hypoxia inducible factor-1α small interfering RNA and 5-fluorouracil to overcome drug resistance in gastric cancer SGC-7901 cells.
Chen Y; Sun L; Guo D; Wu Z; Chen W
J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29106062
[TBL] [Abstract][Full Text] [Related]
8. In vitro silencing effect of chitosan nanoplexes containing siRNA expressing vector targeting VEGF in breast cancer cell lines.
Salva E; Akbuğa J
Pharmazie; 2010 Dec; 65(12):896-902. PubMed ID: 21284259
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the therapeutic efficacy of codelivery of psiRNA-vascular endothelial growth factor and pIL-4 into chitosan nanoparticles in the breast tumor model.
Şalva E; Turan SO; Kabasakal L; Alan S; Özkan N; Eren F; Akbuğa J
J Pharm Sci; 2014 Mar; 103(3):785-95. PubMed ID: 24357345
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of VEGF siRNA and Etoposide for Enhanced Anti-angiogenesis and Anti-proliferation Effect
Li F; Wang Y; Chen WL; Wang DD; Zhou YJ; You BG; Liu Y; Qu CX; Yang SD; Chen MT; Zhang XN
Theranostics; 2019; 9(20):5886-5898. PubMed ID: 31534526
[TBL] [Abstract][Full Text] [Related]
11. Comparison of VEGF gene silencing efficiencies of chitosan and protamine complexes containing shRNA.
Erdem-Çakmak F; Özbaş-Turan S; Şalva E; Akbuğa J
Cell Biol Int; 2014 Nov; 38(11):1260-70. PubMed ID: 24890139
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.
Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037
[TBL] [Abstract][Full Text] [Related]
13. Nanocomposite-siRNA approach for down-regulation of VEGF and its receptor in myeloid leukemia cells.
Wang L; Zhang WJ; Xiu B; Ding Y; Li P; Ye WD; Zhu Q; Liang AB
Int J Biol Macromol; 2014 Feb; 63():49-55. PubMed ID: 24183807
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract][Full Text] [Related]
15. Efficient downregulation of VEGF in retinal pigment epithelial cells by integrin ligand-labeled liposome-mediated siRNA delivery.
Chen CW; Yeh MK; Shiau CY; Chiang CH; Lu DW
Int J Nanomedicine; 2013; 8():2613-27. PubMed ID: 23901275
[TBL] [Abstract][Full Text] [Related]
16. Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating.
Jagani HV; Josyula VR; Palanimuthu VR; Hariharapura RC; Gang SS
Eur J Pharm Sci; 2013 Mar; 48(4-5):611-8. PubMed ID: 23291045
[TBL] [Abstract][Full Text] [Related]
17. siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene.
Zhang C; Tang N; Liu X; Liang W; Xu W; Torchilin VP
J Control Release; 2006 May; 112(2):229-39. PubMed ID: 16545478
[TBL] [Abstract][Full Text] [Related]
18. Efficient inhibition of uveal melanoma via ternary siRNA complexes.
Xie L; Yang Y; Shen J
Int J Pharm; 2020 Jan; 573():118894. PubMed ID: 31765784
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of gambogenic acid and VEGF-siRNA with anionic liposome and polyethylenimine complexes to HepG2 cells.
Yu Q; Zhang B; Zhou Y; Ge Q; Chang J; Chen Y; Zhang K; Peng D; Chen W
J Liposome Res; 2019 Dec; 29(4):322-331. PubMed ID: 29745740
[No Abstract] [Full Text] [Related]
20. The development of ternary nanoplexes for efficient small interfering RNA delivery.
Şalva E; Turan SÖ; Akbuğa J
Biol Pharm Bull; 2013; 36(12):1907-14. PubMed ID: 24432377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
